logo

For the Inventor, By the Inventor

Kessel-lo, Belgium

Paul N Holvoet

This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Leuven Research & Development Vzw, Katholieke Universiteit Leuven. Active years: 2001-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul N Holvoet. Retrieved from https://idiyas.com/inventor/paul-n-holvoet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 40.0

 

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 90(Granted Patents)


Company Filing History:

goldMedal9 out of 26 
 
Leuven Research & Development Vzw
 patents
silverMedal1 out of 631 
 
Katholieke Universiteit Leuven
 patents

Years Active: 2001-2020

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 10704097 - Oxidative stress and cardiovascular disease events (2020-07-07),
2. 7604952 - Detection and determination of the stages of coronary artery disease (2009-10-20),
3. 7579159 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2009-08-25),
4. 7390627 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2008-06-24),
5. 7378250 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2008-05-27),
6. 7229776 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2007-06-12),
7. 7229775 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2007-06-12),
8. 7166469 - Detection and determination of the stages of coronary artery disease (2007-01-23),
9. 6727102 - Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins (2004-04-27),
10. 6309888 - Detection and determination of the stages of coronary artery disease (2001-10-30),

Title: Examining the Innovative Work of Inventor Paul N Holvoet

Introduction:

Paul N Holvoet, a noteworthy inventor hailing from Kessel-Lo, Belgium, has made significant contributions to the field of healthcare with his groundbreaking innovations. With an impressive portfolio of 10 patents, Holvoet's work focuses on the diagnosis and prognosis of cardiovascular diseases, revolutionizing the way these conditions are identified and managed.

Latest Patents:

Holvoet's recent patents showcase his expertise in addressing oxidative stress and cardiovascular disease events. One of his inventions involves determining a prognostic risk score related to cardiovascular events by analyzing deregulated genes in isolated monocytes. Factors such as low expression of COX1, COX4I1, TFAM, and RUNX2 are considered in this innovative diagnostic approach. Another patent highlights a method for detecting and classifying stages of coronary artery disease based on specific markers like OxLDL, MDA-modified LDL, and troponin, providing crucial insights for patient care.

Career Highlights:

Throughout his career, Holvoet has been associated with prominent institutions like Leuven Research & Development Vzw and Katholieke Universiteit Leuven. His dedication to advancing medical science through cutting-edge research has earned him recognition as a leader in the field of cardiovascular health.

Collaborations:

Holvoet has had the privilege of collaborating with esteemed professionals in the industry, including his coworkers Désiré José Collen and Désiré J Collen. Together, they have worked on pioneering projects that have transformed the landscape of cardiovascular disease management.

Conclusion:

Inventor Paul N Holvoet's relentless pursuit of excellence in the realm of healthcare innovation has undoubtedly made a lasting impact on the field of cardiovascular medicine. His patents stand as a testament to his ingenuity and commitment to improving patient outcomes through advanced diagnostic tools and prognostic indicators. Through his noteworthy contributions, Holvoet has solidified his position as a trailblazer in the world of medical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…